Laboratorios Rubió

Laboratorios Rubió is a leading player in the Biopharma, Biotechnology, and Pharmaceutical industries. With a history dating back to 1964, its commitment to making medications accessible to all, regardless of prevalence, is evident. The company prides itself on its pioneering spirit, having introduced the first drug in Spain for the treatment of ADHD. Moreover, with more than a dozen medications on the market, many of which are considered benchmarks in treating specific diseases or disorders, Laboratorios Rubió has established a strong foothold in the healthcare sector. In-house production and sustained investment in R&D are key differentiators for Laboratorios Rubió. The company also boasts significant international certifications, including the renowned FDA certification, and collaborations with leading partners. Despite its international presence, Laboratorios Rubió continues to maintain its identity as a 100% family-owned company with a long-term vision. The company's dedication to accessibility, its expanding product portfolio, and its commitment to international growth through prioritizing its own products position Laboratorios Rubió as a promising venture for potential investors to consider.